These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20150846)

  • 1. Insulin resistance as a novel therapeutic target in patients with chronic kidney disease treated with dialysis.
    Wesołowski P; Saracyn M; Nowak Z; Wańkowicz Z
    Pol Arch Med Wewn; 2010; 120(1-2):54-7. PubMed ID: 20150846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peritoneal dialysis and insulin resistance in patients with chronic kidney disease due to nondiabetic nephropathy].
    Wesołowski P; Saracyn M; Nowak Z; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):359-63. PubMed ID: 18634374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk in peritoneal dialysis.
    Prichard S
    Contrib Nephrol; 2003; (140):82-90. PubMed ID: 12800347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis.
    García-López E; Carrero JJ; Suliman ME; Lindholm B; Stenvinkel P
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S205-9. PubMed ID: 17556305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucotoxicity in peritoneal dialysis--solutions for the solution!
    Holmes CJ
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):269-78. PubMed ID: 17603981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis: Hypokalaemia and cardiac risk in peritoneal dialysis patients.
    Kwan BC; Szeto CC
    Nat Rev Nephrol; 2012 Sep; 8(9):501-3. PubMed ID: 22801950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated analysis of estimated insulin resistance using the HOMAIR index in nondiabetic patients on peritoneal dialysis and its relationship with cardiovascular disease and mortality.
    Sánchez-Villanueva R; Estrada P; del Peso G; Grande C; Díez JJ; Iglesias P; González E; Aguilar-Rodríguez A; Selgas R; Bajo MA; ;
    Nefrologia; 2013 Jan; 33(1):85-92. PubMed ID: 23364630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal dialysis and cardiovascular disease.
    Balafa O; Krediet RT
    Minerva Urol Nefrol; 2012 Sep; 64(3):153-62. PubMed ID: 22971680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
    Amici G; Orrasch M; Da Rin G; Bocci C
    Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal Dialysis in the Obese Patient.
    Kennedy C; Bargman J
    Clin J Am Soc Nephrol; 2020 Feb; 15(2):276-278. PubMed ID: 31740573
    [No Abstract]   [Full Text] [Related]  

  • 12. Strategies for improving long-term survival in peritoneal dialysis patients.
    Kendrick J; Teitelbaum I
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1123-31. PubMed ID: 20430945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
    MacLeod A; Grant A; Donaldson C; Khan I; Campbell M; Daly C; Lawrence P; Wallace S; Vale L; Cody J; Fitzhugh K; Montague G; Ritchie C
    Health Technol Assess; 1998; 2(5):1-166. PubMed ID: 9621129
    [No Abstract]   [Full Text] [Related]  

  • 14. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
    Canbakan M; Sahin GM
    Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in joints during the hemo- and peritoneal dialysis].
    Pasić I; Popović V; Susić H
    Med Arh; 1974 Jan; 28(0):suppl:41-3. PubMed ID: 4839882
    [No Abstract]   [Full Text] [Related]  

  • 16. [Report of the Andalusian registry of patients with end stage renal disease in treatment with peritoneal dialysis: period 1999-2004].
    Remón C; Quirós PL; Pérez Bañasco V; Torán D; Tejuca F; Merino MJ; Guerrero J; Ruiz A; Páez MC; Martínez E; Espigares MJ; González L; Martín G; Castro P; Fernández E
    Nefrologia; 2006; 26(1):45-55. PubMed ID: 16649425
    [No Abstract]   [Full Text] [Related]  

  • 17. Morbidity and mortality of dialysis.
    NIH Consens Statement; 1993 Nov 1-3; 11(2):1-33. PubMed ID: 8004133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term experience with chronic peritoneal dialysis.
    Dombros N; Izatt S; Khanna R; Vogl R; Zellerman G; Meema HE; Blair RD; Oreopoulos DG
    Proc Clin Dial Transplant Forum; 1980; 10():105-8. PubMed ID: 6810337
    [No Abstract]   [Full Text] [Related]  

  • 19. Consequences of chronic inflammation in peritoneal dialysis.
    Wang AY
    Semin Nephrol; 2011 Mar; 31(2):159-71. PubMed ID: 21439430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
    Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.